-
1
-
-
33646530080
-
Is hypertension an inflammatory process?
-
Boos CJ, Lip GY. Is hypertension an inflammatory process? Curr Pharm Des 2006;12: 1623-1635.
-
(2006)
Curr Pharm des
, vol.12
, pp. 1623-1635
-
-
Boos, C.J.1
Lip, G.Y.2
-
2
-
-
34548183984
-
Matrix metalloproteinases: Useful and deleterious
-
Ganea E, Trifan M, Laslo AC, Putina G, Cristescu C. Matrix metalloproteinases: useful and deleterious. Biochem Soc Trans 2007;35: 689-691.
-
(2007)
Biochem Soc Trans
, vol.35
, pp. 689-691
-
-
Ganea, E.1
Trifan, M.2
Laslo, A.C.3
Putina, G.4
Cristescu, C.5
-
3
-
-
37349082926
-
Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
-
Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008;75: 346-359.
-
(2008)
Biochem Pharmacol
, vol.75
, pp. 346-359
-
-
Raffetto, J.D.1
Khalil, R.A.2
-
4
-
-
34250312341
-
The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases
-
Cauwe B, Van den Steen PE, Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 2007;42: 113-185.
-
(2007)
Crit Rev Biochem Mol Biol
, vol.42
, pp. 113-185
-
-
Cauwe, B.1
Van Den Steen, P.E.2
Opdenakker, G.3
-
5
-
-
49849083714
-
Proteinase activity and receptor cleavage: Mechanism for insulin resistance in spontaneously hypertensive rats
-
DeLano FA, Schmid-Schonbein GW. Proteinase activity and receptor cleavage: Mechanism for insulin resistance in spontaneously hypertensive rats. Hypertension 2008;52: 415-423.
-
(2008)
Hypertension
, vol.52
, pp. 415-423
-
-
Delano, F.A.1
Schmid-Schonbein, G.W.2
-
6
-
-
35148820132
-
Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension
-
Zhou S, Feely J, Spiers JP, Mahmud A. Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension. J Hum Hypertens 2007;21: 861-867.
-
(2007)
J Hum Hypertens
, vol.21
, pp. 861-867
-
-
Zhou, S.1
Feely, J.2
Spiers, J.P.3
Mahmud, A.4
-
7
-
-
0033780333
-
Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy
-
Li-Saw-Hee FL, Edmunds E, Blann AD, Beevers DG, Lip GY. Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy. Int J Cardiol 2000;75: 43-47.
-
(2000)
Int J Cardiol
, vol.75
, pp. 43-47
-
-
Li-Saw-Hee, F.L.1
Edmunds, E.2
Blann, A.D.3
Beevers, D.G.4
Lip, G.Y.5
-
8
-
-
1442274816
-
The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and -9 in essential hypertension
-
Zervoudaki A, Economou E, Pitsavos C, Vasiliadou K, Aggeli C, Tsioufis K, Toutouza M, Stefanadis C, Toutouzas P. The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and -9 in essential hypertension. Am J Hypertens 2004;7: 273-276.
-
(2004)
Am J Hypertens
, vol.7
, pp. 273-276
-
-
Zervoudaki, A.1
Economou, E.2
Pitsavos, C.3
Vasiliadou, K.4
Aggeli, C.5
Tsioufis, K.6
Toutouza, M.7
Stefanadis, C.8
Toutouzas, P.9
-
9
-
-
0033551223
-
Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis
-
Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, Watkins H, Henney AM. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999;99: 1788-1794.
-
(1999)
Circulation
, vol.99
, pp. 1788-1794
-
-
Zhang, B.1
Ye, S.2
Herrmann, S.M.3
Eriksson, P.4
De Maat, M.5
Evans, A.6
Arveiler, D.7
Luc, G.8
Cambien, F.9
Hamsten, A.10
Watkins, H.11
Henney, A.M.12
-
10
-
-
33644664088
-
Changes in metalloproteinases in healthy normotensive patients with high-normal blood pressure
-
Papadopoulos DP, Makris TK, Krespi PG, Poulakou M, Papazachou OG, Hatzizacharias AN, Perrea D, Votteas V. Changes in metalloproteinases in healthy normotensive patients with highnormal blood pressure. Eur Cytokine Netw 2005;16: 211-214. (Pubitemid 46638753)
-
(2005)
European Cytokine Network
, vol.16
, Issue.3
, pp. 211-214
-
-
Papadopoulos, D.P.1
Makris, T.K.2
Krespi, P.G.3
Poulakou, M.4
Papazachou, O.G.5
Hatzizacharias, A.N.6
Perrea, D.7
Votteas, V.8
-
11
-
-
36249017215
-
Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension
-
Tan J, Hua Q, Xing X, Wen J, Liu R, Yang Z. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension. Hypertens Res 2007;30: 959-963.
-
(2007)
Hypertens Res
, vol.30
, pp. 959-963
-
-
Tan, J.1
Hua, Q.2
Xing, X.3
Wen, J.4
Liu, R.5
Yang, Z.6
-
12
-
-
33746380241
-
Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension
-
Derosa G, D'Angelo A, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo S, Montagna L, Gravina A, Ferrari I, Galli S, Paniga S, Tinelli C, Cicero AF. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension. Endothelium 2006;13: 227-231.
-
(2006)
Endothelium
, vol.13
, pp. 227-231
-
-
Derosa, G.1
D'Angelo, A.2
Ciccarelli, L.3
Piccinni, M.N.4
Pricolo, F.5
Salvadeo, S.6
Montagna, L.7
Gravina, A.8
Ferrari, I.9
Galli, S.10
Paniga, S.11
Tinelli, C.12
Cicero, A.F.13
-
13
-
-
33646439273
-
Matrix metalloproteinases/tissue inhibitors of metalloproteinases: Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease
-
Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH, McClure CD, Spinale FG, Zile MR. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 2006;113: 2089-2096.
-
(2006)
Circulation
, vol.113
, pp. 2089-2096
-
-
Ahmed, S.H.1
Clark, L.L.2
Pennington, W.R.3
Webb, C.S.4
Bonnema, D.D.5
Leonardi, A.H.6
McClure, C.D.7
Spinale, F.G.8
Zile, M.R.9
-
14
-
-
0032508355
-
Abnormalities of the extracellular degradation of collagen type i in essential hypertension
-
Laviades C, Varo N, Fernandez J, Mayor G, Gil MJ, Monreal I, Diez J. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 1998;98: 535-540.
-
(1998)
Circulation
, vol.98
, pp. 535-540
-
-
Laviades, C.1
Varo, N.2
Fernandez, J.3
Mayor, G.4
Gil, M.J.5
Monreal, I.6
Diez, J.7
-
15
-
-
36448992977
-
ACE inhibitors to block MMP-9 activity: New functions for old inhibitors
-
Jin Y, Han HC, Lindsey ML. ACE inhibitors to block MMP-9 activity: New functions for old inhibitors. J Mol Cell Cardiol 2007;43: 664-666.
-
(2007)
J Mol Cell Cardiol
, vol.43
, pp. 664-666
-
-
Jin, Y.1
Han, H.C.2
Lindsey, M.L.3
-
16
-
-
0037291886
-
Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment
-
Zervoudaki A, Economou E, Stefanadis C, Pitsavos C, Tsioufis K, Aggeli C, Vasiliadou K, Toutouza M, Toutouzas P. Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment. J Hum Hypertens 2003;17: 119-124.
-
(2003)
J Hum Hypertens
, vol.17
, pp. 119-124
-
-
Zervoudaki, A.1
Economou, E.2
Stefanadis, C.3
Pitsavos, C.4
Tsioufis, K.5
Aggeli, C.6
Vasiliadou, K.7
Toutouza, M.8
Toutouzas, P.9
-
17
-
-
0034805565
-
Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells
-
Jiang MC, Liao CF, Lee PH. Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells. Biochem Biophys Res Commun 2001;282: 671-677.
-
(2001)
Biochem Biophys Res Commun
, vol.282
, pp. 671-677
-
-
Jiang, M.C.1
Liao, C.F.2
Lee, P.H.3
-
18
-
-
33144474495
-
Role of angiotensin II receptor blockers in atherosclerotic plaque stability
-
Cipollone F, Fazia ML, Mezzetti A. Role of angiotensin II receptor blockers in atherosclerotic plaque stability. Expert Opin Pharmacother 2006;7: 277-285.
-
(2006)
Expert Opin Pharmacother
, vol.7
, pp. 277-285
-
-
Cipollone, F.1
Fazia, M.L.2
Mezzetti, A.3
-
19
-
-
32344445991
-
Increased levels of atherosclerosis markers in salt-sensitive hypertension
-
Larrousse M, Bragulat E, Segarra M, Sierra C, Coca A, de La Sierra A. Increased levels of atherosclerosis markers in salt-sensitive hypertension. Am J Hypertens 2006;19: 87-93.
-
(2006)
Am J Hypertens
, vol.19
, pp. 87-93
-
-
Larrousse, M.1
Bragulat, E.2
Segarra, M.3
Sierra, C.4
Coca, A.5
De La Sierra, A.6
-
20
-
-
0036629913
-
Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors
-
Chou FP, Chu SC, Cheng MC, Yang SF, Cheung WN, Chiou HL, Hsieh YS. Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors. Clin Biochem 2002;35: 383-388.
-
(2002)
Clin Biochem
, vol.35
, pp. 383-388
-
-
Chou, F.P.1
Chu, S.C.2
Cheng, M.C.3
Yang, S.F.4
Cheung, W.N.5
Chiou, H.L.6
Hsieh, Y.S.7
-
21
-
-
33845419991
-
Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients
-
Pawlak K, Pawlak D, Mysliwiec M. Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients. Atherosclerosis 2007;190: 199-204.
-
(2007)
Atherosclerosis
, vol.190
, pp. 199-204
-
-
Pawlak, K.1
Pawlak, D.2
Mysliwiec, M.3
|